Gene · 407055
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Antipsychotic Drug Aripiprazole Suppresses Colorectal Cancer by Targeting LAMP2a to Induce RNH1/miR-99a/mTOR-Mediated Autophagy and Apoptosis. | Adv Sci (Weinh) | 2024 | 39513392 | PubTator, text mining | PubMed |
| Proceedings 36th Symposium ESVN-ECVN 12th-14th September 2024. | J Vet Intern Med | 2024 | 39511714 | PubTator, text mining | PubMed |
| Lymph node metastasis determined miRNAs in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2024 | 39401765 | PubTator, text mining | PubMed |
| MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study. | Noncoding RNA | 2024 | 39311383 | PubTator, text mining | PubMed |
| Evaluation of circulating miRNAs in mares approaching parturition. | Domest Anim Endocrinol | 2024 | 39191115 | PubTator, text mining | PubMed |
| Genetic Heterogeneity in Cellular Angiofibromas. | Genes Chromosomes Cancer | 2024 | 39120141 | PubTator, text mining | PubMed |
| Analysis of extracellular vesicle microRNA profiles reveals distinct blood and lymphatic endothelial cell origins. | J Extracell Biol | 2024 | 38938681 | PubTator, text mining | PubMed |
| A study of microRNAs as new prognostic biomarkers in anal cancer patients. | Acta Oncol | 2024 | 38899393 | PubTator, text mining | PubMed |
| Exploring the microRNA-mRNA regulatory network associated with solasonine in bladder cancer. | Transl Androl Urol | 2024 | 38855608 | PubTator, text mining | PubMed |
| Low-intensity pulsed ultrasound protects from inflammatory dilated cardiomyopathy through inciting extracellular vesicles. | Cardiovasc Res | 2024 | 38696702 | PubTator, text mining | PubMed |
| Synergistic effects of miR-143 with miR-99a inhibited cell proliferation and induced apoptosis in breast cancer. | Biotechnol Appl Biochem | 2024 | 38689536 | PubTator, text mining | PubMed |
| Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO. | Breast Cancer Res Treat | 2024 | 38689174 | PubTator, text mining | PubMed |
| Retraction Note: Curcumin inhibits proliferation, migration, invasion and promotes apoptosis of retinoblastoma cell lines through modulation of miR-99a and JAK/STAT pathway. | BMC Cancer | 2024 | 38622642 | PubTator, text mining | PubMed |
| Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus. | J Stomatol Oral Maxillofac Surg | 2024 | 38408642 | PubTator, text mining | PubMed |
| Deciphering the role of miR-99a: Implications for prognosis in oral squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2024 | 38367700 | PubTator, text mining | PubMed |
| Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers. | Clin Exp Med | 2024 | 38294554 | PubTator, text mining | PubMed |
| Clinical importance of serum miRNA levels in breast cancer patients. | Discov Oncol | 2024 | 38280134 | PubTator, text mining | PubMed |
| Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation. | Int J Mol Sci | 2024 | 38279330 | PubTator, text mining | PubMed |
| Research progress and perspectives of noncoding RNAs in adrenocortical carcinoma: A review. | Medicine (Baltimore) | 2024 | 38277554 | PubTator, text mining | PubMed |
| IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway. | World J Surg Oncol | 2024 | 38273364 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407055/papers?page=3